Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parini

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|May 16, 2003
Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseasesG Gaipa, M Dassi, P Perseghin, et al.
Clinical Endocrinology|June 21, 2005
Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective studyD Melis, G Parenti, R Gatti, et al.
Journal of Neurology|October 31, 2014
A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutationRita Barone, M Carrozzi, R Parini, et al.
Physiological Reports|February 22, 2026
Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type IIIF Lanfranconi, L Peli, L Pollastri, et al.
American Journal of Human Genetics|January 13, 2000
Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intoleranceM P Sperandeo, M T Bassi, M Riboni, et al.
Clinical Genetics|April 27, 2011
Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA geneL Ferri, C Guido, G la Marca, et al.
Journal of Inherited Metabolic Disease|October 25, 2007
Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation groupB Merinero, B Pérez, C Pérez-Cerdá, et al.
Journal of Neurology|November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsC Angelini, C Semplicini, S Ravaglia, et al.
Pediatrics|November 11, 2009
Multidisciplinary management of Hunter syndromeJoseph Muenzer, M Beck, C M Eng, et al.
Molecular Genetics and Metabolism Reports|July 14, 2017
Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative groupD Concolino, L Amico, M D Cappellini, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|May 16, 2003
Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseasesG Gaipa, M Dassi, P Perseghin, et al.
Clinical Endocrinology|June 21, 2005
Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective studyD Melis, G Parenti, R Gatti, et al.
Journal of Neurology|October 31, 2014
A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutationRita Barone, M Carrozzi, R Parini, et al.
Physiological Reports|February 22, 2026
Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type IIIF Lanfranconi, L Peli, L Pollastri, et al.
American Journal of Human Genetics|January 13, 2000
Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intoleranceM P Sperandeo, M T Bassi, M Riboni, et al.
Clinical Genetics|April 27, 2011
Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA geneL Ferri, C Guido, G la Marca, et al.
Journal of Inherited Metabolic Disease|October 25, 2007
Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation groupB Merinero, B Pérez, C Pérez-Cerdá, et al.
Journal of Neurology|November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsC Angelini, C Semplicini, S Ravaglia, et al.
Pediatrics|November 11, 2009
Multidisciplinary management of Hunter syndromeJoseph Muenzer, M Beck, C M Eng, et al.
Molecular Genetics and Metabolism Reports|July 14, 2017
Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative groupD Concolino, L Amico, M D Cappellini, et al.
Pageof 8